Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Contemporary challenges in the design of topoisomerase II inhibitors for cancer chemotherapy.

× No keyword cloud information.

38 in total

1. Phytochemicals as Anticancer and Chemopreventive Topoisomerase II Poisons.

Authors: Adam C Ketron; Neil Osheroff
Journal: Phytochem Rev Date: 2014-03-01 Impact factor: 5.374

Review 2. Topoisomerases as anticancer targets.

Authors: Justine L Delgado; Chao-Ming Hsieh; Nei-Li Chan; Hiroshi Hiasa
Journal: Biochem J Date: 2018-01-23 Impact factor: 3.857

3. Probing structural requirements for human topoisomerase I inhibition by a novel N1-Biphenyl fluoroquinolone.

Authors: Justine L Delgado; Sarah R C Lentz; Chaitanya A Kulkarni; Pratik R Chheda; Hailey A Held; Hiroshi Hiasa; Robert J Kerns
Journal: Eur J Med Chem Date: 2019-03-20 Impact factor: 6.514

Review 4. Drugging topoisomerases: lessons and challenges.

Authors: Yves Pommier
Journal: ACS Chem Biol Date: 2013-01-04 Impact factor: 5.100

5. Synthesis and antibacterial evaluation of anziaic acid and analogues as topoisomerase I inhibitors.

Authors: Hao Lin; Thirunavukkarasu Annamalai; Priyanka Bansod; Yuk-Ching Tse-Dinh; Dianqing Sun
Journal: Medchemcomm Date: 2013-12-01 Impact factor: 3.597

6. The anticancer multi-kinase inhibitor dovitinib also targets topoisomerase I and topoisomerase II.

Authors: Brian B Hasinoff; Xing Wu; John L Nitiss; Ragu Kanagasabai; Jack C Yalowich
Journal: Biochem Pharmacol Date: 2012-10-05 Impact factor: 5.858

7. Synthesis and evaluation of (18)F-labeled ATP competitive inhibitors of topoisomerase II as probes for imaging topoisomerase II expression.

Authors: Pierre Daumar; Brian M Zeglis; Nicholas Ramos; Vadim Divilov; Kuntal Kumar Sevak; NagaVaraKishore Pillarsetty; Jason S Lewis
Journal: Eur J Med Chem Date: 2014-09-08 Impact factor: 6.514

8. Design, synthesis and biological evaluation of benzimidazole-rhodanine conjugates as potent topoisomerase II inhibitors.

Authors: Penghui Li; Wenjin Zhang; Hong Jiang; Yongliang Li; Changzhi Dong; Huixiong Chen; Kun Zhang; Zhiyun Du
Journal: Medchemcomm Date: 2018-06-02 Impact factor: 3.597

9. Identification of potent catalytic inhibitors of human DNA topoisomerase II by structure-based virtual screening.

Authors: Guoqiang Dong; Ying Wu; Ying Sun; Na Liu; Shanchao Wu; Wannian Zhang; Chunquan Sheng
Journal: Medchemcomm Date: 2018-05-24 Impact factor: 3.597

10. Less toxic zinc(ii), diorganotin(iv), gallium(iii) and cadmium(ii) complexes derived from 2-benzoylpyridine N,N-dimethylthiosemicarbazone: synthesis, crystal structures, cytotoxicity and investigations of mechanisms of action.

Authors: Yan Fang; Jie Li; Pei-Pei Han; Qiu-Xia Han; Ming-Xue Li
Journal: Toxicol Res (Camb) Date: 2018-06-28 Impact factor: 3.524